| Literature DB >> 11522401 |
Abstract
Recently developed technology for DNA vaccination appears to offer the good prospect for the development of a multivalent vaccines that will effectively activate both the humoral and cell mediated mechanisms of the immune system. Currently, DNA vaccination against such important parasitic diseases like malaria, leishmaniosis, toxoplasmosis, cryptosporidiosis, schistosomosis, fasciolosis offers several new opportunities. However, the outcome of vaccination depends very much on vaccine formulations, dose and route of vaccine delivery, and the species and even strain of the vaccinated host. To overcome these problems much research is still needed, specifically focused on cloning and testing of new c-DNA sequences in the following: genome projects: different ways of delivery: design of vectors containing appropriate immunostimulatory sequences and very detailed studies on safety.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11522401 DOI: 10.1016/s0304-4017(01)00478-2
Source DB: PubMed Journal: Vet Parasitol ISSN: 0304-4017 Impact factor: 2.738